1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. EVOLUS INC
Evolus Inc
XNAS: EOLS
6.49 0.10 (1.56%)
248.3K
XNAS Volume

XNAS 08 May, 2026 12:47 PM (EDT)

Watchlist

Portfolio

Alert

Board Meeting
The latest board meeting for Evolus Inc took place on 07 May 2026, for the purpose of Evolus Inc First Quarter Earnings Results for 2026 See details

Evolus Inc - EOLS - stock price prediction, stock price target, analyst ratings from 7 analysts

Evolus Inc has a share price target of US$ 15, revenue growth forecast of 11.2%, and profit growth estimate of 35.5% for FY26, based on top 7 analyst calls.